Sökning: onr:"swepub:oai:DiVA.org:uu-102855" > Greater reduction o...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04666naa a2200577 4500 | |
001 | oai:DiVA.org:uu-102855 | |
003 | SwePub | |
008 | 090512s2008 | |||||||||||000 ||eng| | |
009 | oai:lup.lub.lu.se:ebe8137c-3a9a-4219-9e15-7b5f2a127b90 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-1028552 URI |
024 | 7 | a https://doi.org/10.1160/TH08-05-03132 DOI |
024 | 7 | a https://lup.lub.lu.se/record/12848472 URI |
040 | a (SwePub)uud (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Braun, Oscaru Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)kard-oos |
245 | 1 0 | a Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease |
264 | 1 | c 2008 |
338 | a print2 rdacarrier | |
520 | a Prasugrel, a novel P2Y(12) ADP-receptor antagonist, has been reported to achieve greater inhibition of platelet aggregation compared to clopidogrel as assessed by light transmission aggregometry. It was the objective of this study to investigate the effect of prasugrel on alternative markers of platelet activation in comparison to a high loading dose and the approved maintenance dose of clopidogrel. One hundred ten aspirin-treated patients with stable coronary artery disease were randomized to a loading dose (LD, day 1)/ maintenance dose (MD, days 2-29) of prasugrel 60 mg/10 mg or clopidogrel 600 mg/75 mg. Platelet activation markers were analyzed by whole blood flow cytometry pre-dose and at 2 and 24 hours after LD and pre-dose at 14 and 29 days. After stimulation with 20 muM ADP, 2 hours after LD, significantly lower expression of activated GPIIb/IIIa (4.3 vs. 21.8 [mean fluorescent intensity (MFI)], p < 0.001) and P-selectin (2.0 vs. 11.7 MFI, p < 0.001) along with decreased formation of platelet-monocyte aggregates (16.4% vs. 29.6% positive cells, p < 0.001) was observed with prasugrel versus clopidogrel. All these effects were maintained through 24 hours and during the MD period. In conclusion, prasugrel 60 mg LD and 10 mg MD inhibit several markers of platelet activation and the formation of platelet-monocyte aggregates more effectively than a 600 mg LD and 75 mg MD of clopidogrel. Attenuated platelet aggregation and reduced expression of platelet pro-coagulant and pro-inflammatory markers with prasugrel suggest the potential to reduce cardiovascular events both in the acute setting and in long-term treatment. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng |
653 | a CAD | |
653 | a thienopyridines | |
653 | a platelet markers | |
653 | a tissue factor | |
653 | a flow cytometry | |
653 | a MEDICINE | |
653 | a MEDICIN | |
653 | a flow cytometry | |
653 | a tissue factor | |
653 | a platelet markers | |
653 | a CAD | |
653 | a thienopyridines | |
700 | 1 | a Johnell, Matildau Uppsala universitet,Institutionen för medicinska vetenskaper4 aut |
700 | 1 | a Varenhorst, Christophu Uppsala universitet,Institutionen för medicinska vetenskaper,UCR4 aut0 (Swepub:uu)chrva923 |
700 | 1 | a James, Stefan,d 1964-u Uppsala universitet,Institutionen för medicinska vetenskaper,UCR4 aut0 (Swepub:uu)stjam367 |
700 | 1 | a Brandt, John T.4 aut |
700 | 1 | a Jakubowski, Joseph A.4 aut |
700 | 1 | a Winters, Kenneth J.4 aut |
700 | 1 | a Wallentin, Lars,d 1943-u Uppsala universitet,Institutionen för medicinska vetenskaper,UCR4 aut0 (Swepub:uu)larswall |
700 | 1 | a Erlinge, Davidu Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)kard-der |
700 | 1 | a Siegbahn, Agneta,d 1947-u Uppsala universitet,Institutionen för medicinska vetenskaper4 aut0 (Swepub:uu)agsie424 |
710 | 2 | a Kardiologib Sektion II4 org |
773 | 0 | t Thrombosis and Haemostasisg 100:4, s. 626-633q 100:4<626-633x 0340-6245x 2567-689X |
856 | 4 | u http://dx.doi.org/10.1160/TH08-05-0313y FULLTEXT |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-102855 |
856 | 4 8 | u https://doi.org/10.1160/TH08-05-0313 |
856 | 4 8 | u https://lup.lub.lu.se/record/1284847 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy